Annual EBIT
-$88.13 M
+$9.45 M+9.69%
31 December 2023
Summary:
Aligos Therapeutics annual earnings before interest & taxes is currently -$88.13 million, with the most recent change of +$9.45 million (+9.69%) on 31 December 2023. During the last 3 years, it has risen by +$9.71 million (+9.92%). ALGS annual EBIT is now -63.07% below its all-time high of -$51.74 million.ALGS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$20.13 M
+$6.28 M+23.79%
30 September 2024
Summary:
Aligos Therapeutics quarterly earnings before interest & taxes is currently -$20.13 million, with the most recent change of +$6.28 million (+23.79%) on 30 September 2024. Over the past year, it has dropped by -$1.06 million (-5.56%). ALGS quarterly EBIT is now -38.80% below its all-time high of -$14.50 million, reached on 30 September 2019.ALGS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$94.59 M
-$1.06 M-1.13%
30 September 2024
Summary:
Aligos Therapeutics TTM earnings before interest & taxes is currently -$94.59 million, with the most recent change of -$1.06 million (-1.13%) on 30 September 2024. Over the past year, it has dropped by -$9.78 million (-11.53%). ALGS TTM EBIT is now -552.15% below its all-time high of -$14.50 million, reached on 30 September 2019.ALGS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALGS EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +9.7% | -5.6% | -11.5% |
| 3 y3 years | +9.9% | +39.1% | +24.1% |
| 5 y5 years | - | -38.8% | -552.1% |
ALGS EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +31.3% | -6.2% | +47.0% | -11.7% | +30.5% |
| 5 y | 5 years | -63.1% | +31.3% | -38.8% | +47.0% | -552.1% | +30.5% |
| alltime | all time | -63.1% | +31.3% | -38.8% | +47.0% | -552.1% | +30.5% |
Aligos Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$20.13 M(-23.8%) | -$94.59 M(+1.1%) |
| June 2024 | - | -$26.41 M(+19.8%) | -$93.53 M(+8.4%) |
| Mar 2024 | - | -$22.05 M(-15.2%) | -$86.25 M(-2.1%) |
| Dec 2023 | -$88.13 M(-9.7%) | -$26.00 M(+36.3%) | -$88.13 M(+3.9%) |
| Sept 2023 | - | -$19.07 M(-0.4%) | -$84.81 M(+0.1%) |
| June 2023 | - | -$19.14 M(-20.0%) | -$84.69 M(-1.5%) |
| Mar 2023 | - | -$23.92 M(+5.4%) | -$85.94 M(-11.9%) |
| Dec 2022 | -$97.58 M | -$22.68 M(+19.7%) | -$97.58 M(-13.5%) |
| Sept 2022 | - | -$18.95 M(-7.1%) | -$112.85 M(-11.1%) |
| June 2022 | - | -$20.39 M(-42.6%) | -$126.97 M(-6.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$35.56 M(-6.3%) | -$136.14 M(+6.1%) |
| Dec 2021 | -$128.32 M(+31.2%) | -$37.95 M(+14.8%) | -$128.32 M(+2.9%) |
| Sept 2021 | - | -$33.07 M(+11.8%) | -$124.66 M(+10.2%) |
| June 2021 | - | -$29.57 M(+6.6%) | -$113.15 M(+7.9%) |
| Mar 2021 | - | -$27.74 M(-19.1%) | -$104.85 M(+7.2%) |
| Dec 2020 | -$97.83 M(+81.0%) | -$34.29 M(+59.0%) | -$97.83 M(+19.3%) |
| Sept 2020 | - | -$21.56 M(+1.3%) | -$81.98 M(+9.4%) |
| June 2020 | - | -$21.27 M(+2.7%) | -$74.93 M(+39.6%) |
| Mar 2020 | - | -$20.72 M(+12.4%) | -$53.66 M(+62.9%) |
| Dec 2019 | -$54.04 M | -$18.44 M(+27.1%) | -$32.94 M(+127.1%) |
| Sept 2019 | - | -$14.50 M | -$14.50 M |
FAQ
- What is Aligos Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Aligos Therapeutics?
- What is Aligos Therapeutics annual EBIT year-on-year change?
- What is Aligos Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Aligos Therapeutics?
- What is Aligos Therapeutics quarterly EBIT year-on-year change?
- What is Aligos Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Aligos Therapeutics?
- What is Aligos Therapeutics TTM EBIT year-on-year change?
What is Aligos Therapeutics annual earnings before interest & taxes?
The current annual EBIT of ALGS is -$88.13 M
What is the all time high annual EBIT for Aligos Therapeutics?
Aligos Therapeutics all-time high annual earnings before interest & taxes is -$51.74 M
What is Aligos Therapeutics annual EBIT year-on-year change?
Over the past year, ALGS annual earnings before interest & taxes has changed by +$9.45 M (+9.69%)
What is Aligos Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of ALGS is -$20.13 M
What is the all time high quarterly EBIT for Aligos Therapeutics?
Aligos Therapeutics all-time high quarterly earnings before interest & taxes is -$14.50 M
What is Aligos Therapeutics quarterly EBIT year-on-year change?
Over the past year, ALGS quarterly earnings before interest & taxes has changed by -$1.06 M (-5.56%)
What is Aligos Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of ALGS is -$94.59 M
What is the all time high TTM EBIT for Aligos Therapeutics?
Aligos Therapeutics all-time high TTM earnings before interest & taxes is -$14.50 M
What is Aligos Therapeutics TTM EBIT year-on-year change?
Over the past year, ALGS TTM earnings before interest & taxes has changed by -$9.78 M (-11.53%)